The cost of Entresto without insurance can vary significantly depending on the pharmacy and specific dosage. A 30-day supply of Entresto can range from approximately $450 to $570 or more [1].
What factors influence Entresto pricing?
Several factors contribute to the retail price of Entresto. These include the drug's formulation, the dosage prescribed, and the dispensing pharmacy's pricing policies. The wholesale acquisition cost, which is the price manufacturers set for their drugs, also plays a role, though this is distinct from the price consumers pay at the pharmacy [2].
Are there ways to reduce the cost of Entresto without insurance?
Patients without insurance coverage may explore various options to lower their out-of-pocket expenses for Entresto. These can include seeking manufacturer-sponsored patient assistance programs, which may offer eligible individuals significant discounts or free medication. Additionally, comparing prices at different pharmacies can reveal cost savings, as retail markups can differ. Exploring discount cards or coupons from third-party providers might also yield lower prices [1].
Does Medicare cover Entresto?
Medicare beneficiaries may have coverage for Entresto, depending on their specific Medicare plan. Most Medicare Part D prescription drug plans include Entresto. The cost for beneficiaries typically depends on the plan's formulary, deductible, and coinsurance. For those with Medicare Advantage plans that include prescription drug coverage, Entresto may also be covered, with costs varying by plan [1].
What is Entresto used for?
Entresto (sacubitril/valsartan) is a prescription medication used to treat heart failure with reduced ejection fraction in certain adult patients [1]. It works by combining two medications that help reduce the strain on the heart [1].
When does the patent for Entresto expire?
The patent landscape for Entresto is complex, with multiple patents covering different aspects of the drug. According to DrugPatentWatch.com, the earliest anticipated patent expiry for Entresto could be in the mid-2030s, although this is subject to various legal challenges and extensions [3]. This timeline is crucial for understanding when generic versions might become available.
What is the difference between Entresto and other heart failure treatments?
Entresto is a specific type of medication, a combination of sacubitril and valsartan, designed for heart failure with reduced ejection fraction. It represents a distinct therapeutic approach compared to other heart failure medications that might include ACE inhibitors, beta-blockers, or diuretics, which work through different mechanisms [1].
How does Entresto compare to generic alternatives?
Currently, there are no generic versions of Entresto available on the market. The drug is protected by patents, and its patent expiries will determine when generic competition can emerge. Until then, only the brand-name medication is available [3].
---
Sources
1. Novartis. Entresto Patient Information. Retrieved from https://www.entresto.com/patient-info
2. GoodRx. Entresto Prices, Coupons, and Patient Assistance Programs. Retrieved from https://www.goodrx.com/entresto
3. DrugPatentWatch. Entresto Patent Expiry. Retrieved from https://www.drugpatentwatch.com/drug/entresto